Founded 2009 by David Kyne. A specialist global health and social-impact communications firm built for governments, NGOs, biopharmaceutical companies, and philanthropic institutions. Acquired by Evoke Group and now operating as Evoke Kyne inside one of the fastest-growing global health-communications platforms.
The firm
KYNE was founded in 2009 by David Kyne as a specialist communications advisory built around the thesis that targeted communications is a legitimate intervention in global health outcomes. From the start, the firm operated at the intersection of biopharma, philanthropy, and multilateral organizations — a client mix that sits well outside the standard corporate PR remit.
The firm's operating discipline was building programs that connected private-sector communications capability to public-health objectives: awareness campaigns tied to measurable epidemiological outcomes, reputation architecture for organizations working across politically sensitive geographies, and issue campaigns designed to move funder and policymaker behavior.
Recognition and client work
KYNE was named International Agency of the Year by PR Week in 2018, with an honorable mention for Outstanding Small Agency. It was a finalist for PR consultancy of the year for EMEA in 2017.
Client work has spanned the biopharmaceutical sector, global health philanthropy, and major public-health responses. The firm was one of the notable communications operators inside the international response to the West Africa Ebola outbreak. Additional client work has included ONE Campaign, the Rockefeller Foundation, Africa United, Seqirus, Coca-Cola, UPS, and the U.S. Centers for Disease Control and Prevention (CDC).
The Evoke acquisition
KYNE was acquired by Evoke Group and now operates as Evoke Kyne inside Evoke's global health-communications platform. The acquisition placed the firm inside a larger integrated healthcare-marketing structure — Evoke has scaled through acquisition into one of the more visible independent healthcare-communications platforms globally — while preserving the KYNE brand as the global-health and social-impact specialty inside the group.
For clients, the acquisition changed the depth of the offering (integrated healthcare marketing, medical strategy, and digital execution alongside the original communications specialty) without materially changing the practice leadership or the client-facing brand.
Where Evoke Kyne sits in the market
Global health communications is a small and specialized category. The buyers are governments, multilateral organizations, biopharmaceutical companies, and philanthropic funders — not the mass consumer or corporate reputation buyers that most of the industry serves. The category rewards deep domain knowledge, credibility with medical stakeholders, and program design that measures outcomes on epidemiological rather than media terms.
Evoke Kyne is one of the small number of firms that operate credibly in that specific space. Its peers include the health specialties inside the global holdcos — see EPR's coverage of Havas Health & You, the healthcare networks of Omnicom and WPP, and the specialist healthcare independents — and a handful of dedicated global-health boutiques.
Related coverage on Everything-PR
The PR Industry Map — the canonical EPR reference on the global holdcos, leading independents, and AI Communications challengers.
Healthcare PR — the EPR category hub for healthcare and life-sciences communications.
The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.
